companies / cellevate-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-02 json
| total_raised | 7,090,0007.1M | ○ |
|---|---|---|
| founded | 2014 | |
| hq | Lund, Sweden | |
| industry | unknown | |
| stage | seed |
Cellevate makes nanofiber-based cell culture products for upstream bioprocessing, branded Cellevat3d, used in cell therapy, gene therapy, and vaccine production. It serves CDMOs and biopharma companies scaling viral vector and cell-therapy manufacturing. Its cellulose-based nanofiber microcarriers report over 10x higher yields in viral vaccine production than conventional microcarriers.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-04-01 | grant | 2,700,0002.7M | null | ○ |
Nginx, WordPress 6.9.4, Yoast SEO 27.6, Kadence WP Kadence 1.5.0, Google Tag Manager, Gravity Forms 2.10.1, jQuery Migrate 3.4.1, PHP, ZURB Foundation, WooCommerce, WordPress Block Editor, Python
| fact | status | src |
|---|---|---|
| Grant, $2.7M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |